The former category in both classifications includes MDS with isolated del 5q, MDS with SF3B1 mutation, MDS with bi-allelic TP53 inactivation (WHO) (Figure 1), and MDS with mutated TP53 (ICC). This evidence concerns the gene SF3B1 and myelodysplastic syndrome.